Court restricts abortion access across U.S. by blocking the mailing of mifepristone
PBS • • nation
Key Points:
- The 5th U.S. Circuit Court of Appeals has blocked the mailing of mifepristone, restricting the abortion pill's distribution to in-person clinic visits only.
- The court's ruling emphasizes that FDA-facilitated abortions conflict with Louisiana's policy recognizing unborn children as legal persons from conception.
- Since the Supreme Court's 2022 overturning of Roe v. Wade, mailed prescriptions for abortion pills have become a primary method for accessing abortion, especially in states with bans.
- The ACLU warns that restricting telemedicine access to abortion pills disproportionately harms rural communities, low-income individuals, people with disabilities, survivors of intimate partner violence, and communities of color.
